Role of nucleotide-binding and oligomerization domain 2 protein (NOD2) in the development of Atherosclerosis

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

NOD2 (nucleotide-binding and oligomerization domain 2) was initially reported as a susceptibility gene for Crohn's disease, with several studies focused on elucidating its molecular mechanism in the progression of Crohn's disease. We now know that NOD2 is an intracellular bacterial sensing receptor, and that MDP-mediated NOD2 activation drives inflammatory signaling. Various mutations in NOD2 have been reported, with NOD2 loss of function being associated with the development of Crohn's disease and other autoimmune diseases. These results suggest that NOD2 not only has an immune stimulatory function, but also an immune regulatory function. Atherosclerosis is a chronic inflammatory disease of the arterial wall; its pathologic progression is highly dependent on the immune balance. This immune balance is regulated by infiltrating monocytes and macrophages, both of which express NOD2. These findings indicate a potential role of NOD2 in atherosclerosis. The purpose of this review is to outline the known roles of NOD2 signaling in the pathogenesis of atherosclerosis.

Original languageEnglish
Pages (from-to)479-484
Number of pages6
JournalKorean Journal of Physiology and Pharmacology
Volume19
Issue number6
DOIs
StatePublished - Nov 2015

Keywords

  • Atherosclerosis
  • Chronic inflammatory disease
  • Immune balance
  • NOD2

Fingerprint

Dive into the research topics of 'Role of nucleotide-binding and oligomerization domain 2 protein (NOD2) in the development of Atherosclerosis'. Together they form a unique fingerprint.

Cite this